Adrian I Bot
Impact in
- Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Immunology 58
- Immunotherapy and Immune Responses 43
- T-cell and B-cell Immunology 10
- Immune Response and Inflammation 9
- Oncology 60
- CAR-T cell therapy research 50
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- Simona Bot (19 shared papers)John M. Rossi (23 shared papers)Constantin A. Bona (23 shared papers)Allen Xiaodong Xue (6 shared papers)William Y. Go (14 shared papers)Sattva Swarup Neelapu (12 shared papers)Frederick Lundry Locke (13 shared papers)Armin Ghobadi (7 shared papers)
- Journals
- International Reviews of Immunology (21 papers)Blood (11 papers)Journal of Immunotherapy (7 papers)Journal for ImmunoTherapy of Cancer (6 papers)European Journal of Immunology (5 papers)
- Partner nations
- United StatesSwitzerlandIndia
In The Last Decade
Adrian I Bot
145 papers receiving 13k citations
Adrian I Bot's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 8.7k
- Immunology 1.9k
- Pathology and Forensic Medicine 1.3k
- Immunology and Allergy 155
- Hematology 369
Countries citing papers authored by Adrian I Bot
This map shows the geographic impact of Adrian I Bot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian I Bot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian I Bot more than expected).
Fields of papers citing papers by Adrian I Bot
This network shows the impact of papers produced by Adrian I Bot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian I Bot. The network helps show where Adrian I Bot may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian I Bot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 153 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Hit paper breakdown → | 2017 | 4779 |
| 2 | Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial Hit paper breakdown → | 2018 | 1879 |
| 3 | Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma Hit paper breakdown → | 2017 | 536 |
| 4 | 2017 | 496 | |
| 5 | Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma Hit paper breakdown → | 2020 | 395 |
| 6 | TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers Hit paper breakdown → | 2021 | 280 |
| 7 | 2018 | 277 | |
| 8 | 2020 | 263 | |
| 9 | 2017 | 245 | |
| 10 | 5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1) Hit paper breakdown → | 2023 | 186 |
| 11 | In vivo CAR T cell generation to treat cancer and autoimmune disease Hit paper breakdown → | 2025 | 177 |
| 12 | 2022 | 171 | |
| 13 | 2008 | 166 | |
| 14 | 1999 | 165 | |
| 15 | 2021 | 163 | |
| 16 | 2021 | 158 | |
| 17 | 2021 | 155 | |
| 18 | 1998 | 128 | |
| 19 | 2005 | 113 | |
| 20 | 2021 | 102 |
About Adrian I Bot
Adrian I Bot is a scholar working on Immunology, Oncology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 153 papers that have together received 13.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (50 papers), Immunotherapy and Immune Responses (43 papers), Influenza Virus Research Studies (18 papers), Cancer Immunotherapy and Biomarkers (12 papers), T-cell and B-cell Immunology (10 papers), Immune Response and Inflammation (9 papers), Diabetes and associated disorders (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Oncology (8.7k citations), Immunology (1.9k citations), Pathology and Forensic Medicine (1.3k citations), Immunology and Allergy (155 citations) and Hematology (369 citations). Adrian I Bot has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Simona Bot, John M. Rossi, Constantin A. Bona, Allen Xiaodong Xue, William Y. Go, Sattva Swarup Neelapu, Frederick Lundry Locke, Armin Ghobadi, Steven A. Rosenberg and James N. Kochenderfer. Their work appears in journals such as International Reviews of Immunology, Blood, Journal of Immunotherapy, Journal for ImmunoTherapy of Cancer and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.